Back to top

T Rowe Price Health Sciences Fd: (MF: PRHSX)

(MF) As of Apr 17, 2014 06:05 PM ET

 Add to portfolio

$57.80 USD

-0.13 (-0.22%)

Zacks MF Rank : 1 - Strong Buy [?] 1        

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Mar 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Mar 31, 2014) 5.98
Objective* Equity - Sector Health
Peer* HL MG

*Key

Zacks Premium Research for PRHSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Strong Buy 1
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 42.72
Net Assets (Mil $) 3/31/2014 8,578.00
%Turnover 3/31/2014 45.70

Allocation

% of Portfolio
Large Growth 22.40
Large Value 0.00
Small Growth 3.94
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 32.86
High Yield Bond 16.95

Sector / Country Weightings

As of 3/31/2014 % of Portfolio
Health 42.87
Services 17.38
Finance 12.10
Other 8.97
Retail Trade 6.31
Technology 6.30
Industrial Cyclical 5.14
Non-Durable 0.93

Portfolio Holdings

Top Equity Holdings
(As of 12/31/2013)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 7.60 651.78
ALEXION PHARMACEUTICALS I 4.53 388.42
BIOGEN IDEC INC 3.13 268.90
UNITEDHEALTH GROUP INC 2.97 255.02
VALEANT PHARMACEUTICALS 2.95 253.30
AGILENT TECHNOLOGIES INC 2.89 247.51
INCYTE PHARMACEUTICALS IN 2.87 245.84
MCKESSON CORP 2.65 227.54
PHARMACYCLICS INC 2.53 217.14

Stock Holding % of Net Assets

As Of 12/31/2013
Total Issues 149
Avg. P/E 27.32
Avg. P/Book 4.62
Avg. EPS Growth 15.24
Avg. Market Value (Mil $) 32,442

Risk

3 Year 5 Year 10 Year
Beta 0.94 0.83 0.88
Alpha 13.06 11.40 8.12
R Squared 0.57 0.57 0.63
Std. Dev. 15.47 15.46 16.44
Sharpe 1.89 2.03 1.00